African American Women Bear Unequal Burden for Deadly Disease
Posted on: Wednesday, 19 April 2006, 15:00 CDT
NEW YORK, April 19 /PRNewswire/ -- THIS IS A HEALTH NEWS UPDATE. COMPARED TO ANY GENDER, RACE, OR ETHNICITY, AFRICAN AMERICAN WOMEN HAVE THE GREATEST RISK OF DYING FROM COLORECTAL CANCER. A RECENT HARRIS POLL REVEALED THAT NINETY-SIX PERCENT OF AFRICAN AMERICAN WOMEN OVER AGE FORTY-FIVE DO NOT CONSIDER THEMSELVES TO BE AT HIGH RISK FOR THE DISEASE.
IN RESPONSE, THE BLACK WOMEN'S HEALTH IMPERATIVE AND THE NATIONAL WOMEN'S HEALTH RESOURCE CENTER ARE CHALLENGING AFRICAN AMERICAN WOMEN TO DARE TO BE AWARE OF THEIR COLORECTAL CANCER RISK AND TAKE ACTION.
DR. EDITH MITCHELL, GASTROINTESTINAL ONCOLOGIST AT THOMAS JEFFERSON UNIVERSITY:
"Colorectal cancer does not have to be a death sentence. If screening reveals a tumor, there are many viable options for therapy that could include surgery, radiation, targeted therapies, chemotherapy and oral chemotherapy, which may help some patients continue to work or spend time with family and friends. We strongly encourage African American women to confront their risk for colon and rectal cancer, get the facts and take action!"
FOR MORE VISIT BLACKWOMENSHEALTH.ORG OR HEALTHYWOMEN.ORG. I'M CHRISTIANE ARBESU.
AUDIO PROVIDED BY: BWHI AND NWHRC
Audio: http://www.prnewswire.com/broadcast/24152/consumer.html
BWHI AND NWHRC
CONTACT: FOR STORY INFORMATION, PLEASE CALL: MultiVu Media Relations,1-800-653-5313, EXT. 3 OR EMAIL RADIO@MULTIVU.COM
Web site: http://www.blackwomenshealth.org/
Source: PRNewswire
Related Articles
- Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research
- Study: MRIs for Women at Risk for Cancer
- NICE Initial Recommendation: One Step Closer to Backing Aromatase Inhibitor Treatment for Women With Early Breast Cancer
- Smearing Skin With Broccoli Can Help Reduce Risk of Cancer
- Young Women at Risk for Hidden and Life-Threatening Disorder
- Novartis Submits Applications in U.S. And Europe for Femara As Adjuvant Treatment for Postmenopausal Women With Early Breast Cancer
- Infertility may be predict a risk of cancer
- Little Risk of Cancer Found in Hair Dye
- AVI BioPharma Presents Positive Results With NEUGENE Antisense Drugs At the American Association for Cancer Research Meeting
- OSI Pharmaceuticals Summarizes Pre-Clinical Data From Its Research & Development Program Presented at the 96th Annual Meeting of the American Association for Cancer Research
 |
 |
User Comments (0)
RSS Feeds